Farmaceutisch Tijdschrift voor België – 95ste jaargang nr. 3 - september 2015 35 27 Trissel L.A. (2013) Handbook on injectable drugs, 17th Edition. 28 Vigneron J. Stabilis Website: www.stabilis.org/ geraadpleegd op 21/05/2012. 29 Vigneron J., Astier A., Trittler R., Hecq J.D., Daouphars M., Larsson I., Pourroy B., Pinguet F. (2013) SFPO and ESOP recommandations for the practical stability of anticancer drugs : An update. Annales Pharmaceutiques Françaises 71, 376-389. 30 Samenvatting van de Productkenmerken: Doxorubicine. Teva (2014). 31 Williamson Steve (2011) Guidelines for the dose banding of cancer chemotherapy. NECN dose banding guidelines version 1.4. 32 Coachis Santé (2014) Compte Rendu réunion plénière Club Utilisateurs du 1er avril 2014. 33 Douillard J.Y., Cunningham D., Roth A.D., Navarro M., James R.D., Karasek P., Jandik P., Iveson T., Carmichael J., Alakl M., Gruia G., Awad L., Rougier P. (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer : a multicentre randomised trial. The Lancet 355, 1041-1047. 34 Maindrault-Goebel F., Louvet C., André T., Carola E., Lotz J.P., Molitor J.L., Garcia M.L., Gilles-Amar V., Izrael V., Krulik M., De Gramont A. (1999) Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). European Journal of Cancer 35, 1338-1342. 35 De Gramont A., Bosset J.F., Milan C., Rougier P., Bouché O., Etienne P.L., Morvan F., Louvet C., Guillot T., François E., Bedenne L. (1997) Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advancer colorectal cancer : a French intergroup study. Journal of Clinical Oncology 15, 808-815. 36 Leth-Miller D. (2007) Dose-banding of gemcitabine. European Journal of Hospital Pharmacy 2, 52. 37 North of England cancer Network. {Online} www.networks.nhs.uk geraadpleegd op 10/03/2014. 38 Koninklijk Besluit van 20 januari 2009 houdende onderrichtingen voor de apothekers. Belgisch Staatsblad van 30/01/2009, 7229. 39 Sewell G., Kaestner S. Dosebanding of cancer chemotherapy. Hospital Pharmacy Europe 2010; 51, 31-32. 40 Hoppe-Tichy T. Current challenges in European oncology pharmacy practice. Journal of Oncology Pharmacy Practice 2010 ; 16, 9-18. Onderzoek
Farmaceutisch_Tijdschrift_van_Belgie_nr_3_september
To see the actual publication please follow the link above